The Tumor Microenvironment
Regulation of Angiogenesis and Blood Supply
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Apr 23, 2026

A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds
Published on: April 6, 2016
Neil R Smith1, Dawn Baker2, Matthew Farren2
1Oncology Innovative Medicines, AstraZeneca, Alderley Park, Macclesfield, Cheshire, United Kingdom. neil.n.r.smith@astrazeneca.com simon.t.barry@astrazeneca.com.
No abstract available in PubMed .